 |
|
|
 |
|
Rationale:
- Because treatment may be lifelong, the diagnosis must be established as definitely as possible before long-term treatment
is considered. This definition of gout will avoid use of uric acid-lowering agents in patients with other forms of recurrent
acute arthritis. The differential diagnosis of acute gout also includes articular sepsis, which must be excluded.
|
|
Evidence:
- In the American College of Rheumatology committee report for classification of acute gout, examination of fluid obtained by aspiration of the acutely inflamed joint was 84.4% sensitive
and 100% specific for the diagnosis (12).
- One survey of hospital laboratories showed that 39 of 50 laboratories could identify monosodium urate crystals, but only 6
of 50 correctly identified concomitant crystal-disease crystals (24).
- Evaluation of joint fluid by a rheumatologist may be of more benefit than simple review by a laboratory technician (25).
- Synovial fluid was aspirated from 50 patients with asymptomatic, nontophaceous gout, in whom monosodium urate crystals had
been found in synovial fluid from the knees or other joints. Of these patients, 58% had monosodium urate crystals in their
knee joints (26).
- Synovial fluid was obtained from previously affected gouty knee or metatarsophalangeal joints in 91 of 101 consecutive patients
with gout. All fluid samples from the 43 patients not receiving uric acid-lowering therapies contained monosodium urate crystals,
whereas only 34 of 48 fluid samples showed crystals from those patients receiving uric acid-lowering therapies (27).
- See table Differential Diagnosis of Gout.
|
|
Comments:
- One should observe the monosodium urate crystals in cells to prevent false-positive readings from extraneous birefringent
material on the microscope slide. Inadequate evaluation of fluid may lead to unnecessary joint lavage, arthroscopy, or arthrotomy.
|
| FAQs |
|
|
|
Grace P. Teal, MD (deceased) has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Howard A. Fuchs, MD, is a consultant for TAP Pharmaceuticals. Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.
|
|
|
|
The information included herein should never be used as a substitute
for clinical judgment and does not represent an official position of
ACP. Because all PIER modules are updated regularly, printed web pages
or PDFs may rapidly become obsolete. Therefore, PIER users should
compare the date of the last update on the website with any printout
to ensure that the information being referred to is the most current
available.
|
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.
|
|
|